Manufacturer of Controlled Substances Notice of Registration, 10675-10676 [05-4212]

Download as PDF 10675 Federal Register / Vol. 70, No. 42 / Friday, March 4, 2005 / Notices interstate or foreign commerce, subject to subsection (b). (b) This section shall not be construed to supersede or limit the laws of any State that— (1) Permit private persons or entities to prohibit or restrict the possession of concealed firearms on their property; or (2) Prohibit or restrict the possession of firearms on any State or local government property, installation, building, base, or park. (c) As used in this section, the term ‘‘qualified retired law enforcement officer’’ means an individual who— (1) Retired in good standing from service with a public agency as a law enforcement officer, other than for reasons of mental instability; (2) Before such retirement, was authorized by law to engage in or supervise the prevention, detection, investigation, or prosecution of, or the incarceration of any person for, any violation of law, and had statutory powers of arrest; (3)(A) Before such retirement, was regularly employed as a law enforcement officer for an aggregate of 15 years or more; or (B) Retired from service with such agency, after completing any applicable probationary period of such service, due to a service-connected disability, as determined by such agency; (4) Has a nonforfeitable right to benefits under the retirement plan of the agency; (5) During the most recent 12-month period, has met, at the expense of the individual, the State’s standards for training and qualification for active law enforcement officers to carry firearms; (6) Is not under the influence of alcohol or another intoxicating or hallucinatory drug or substance; and (7) Is not prohibited by Federal law from receiving a firearm. (d) The identification required by this subsection is— (1) A photographic identification issued by the agency from which the individual retired from service as a law enforcement officer that indicates that the individual has, not less recently than one year before the date the individual is carrying the concealed firearm, been tested or otherwise found by the agency to meet the standards established by the agency for training and qualification for active law enforcement officers to carry a firearm of the same type as the concealed firearm; or (2)(A) A photographic identification issued by the agency from which the individual retired from service as a law enforcement officer; and (B) Certification issued by the State in which the individual resides that VerDate jul<14>2003 19:07 Mar 03, 2005 Jkt 205001 indicates that the individual has, not less recently than one year before the date the individual is carrying the concealed firearm, been tested or otherwise found by the State to meet the standards established by the State for training and qualification for active law enforcement officers to carry a firearm of the same type as the concealed firearm. (e) As used in this section, the term ‘firearm’ does not include— (1) Any machinegun (as defined in section 5845 of the National Firearms Act); (2) Any firearm silencer (as defined in section 921 of this title); and (3) A destructive device (as defined in section 921 of this title).’’ 118 Stat. at 866–67. Under these provisions, a person is a retired qualified LEO under the Act if he or she (1) retired in good standing from his or her employing agency (other than for reasons of mental instability); (2) was authorized to perform the specified law enforcement functions and held a position for which powers of arrest were granted by statute; (3) was regularly employed as a law enforcement officer for an aggregate of 15 years or more before his or her retirement, or retired from service with his or her agency (after completing any applicable probationary period of such service) due to a service-connected disability as determined by the agency; (4) has a nonforfeitable right to retirement plan benefits of the law enforcement agency; (5) during the most recent year, has met state firearms training and qualifications that are the same as the training and qualifications for active duty officers; (6) is not under the influence of alcohol or another intoxicating or hallucinatory drug or substance; (7) is not prohibited by Federal law from receiving a firearm; (8) carries a photo identification issued by the agency; and (9) meets an annual qualification requirement. The Department considers the following components to be agencies whose retired employees may qualify as LEOs for purposes of the Act: the Bureau of Alcohol, Tobacco, Firearms, and Explosives; the Drug Enforcement Administration; the Federal Bureau of Investigation; the Federal Bureau of Prisons; the Office of Inspector General, insofar as the retiree exercised statutory law enforcement authority at the time of his retirement; and the United States Marshals Service. As with current employees, any particular retired employee of one of these components independently must meet each of the specified statutory qualifications to qualify as a retired LEO under the Act. PO 00000 Frm 00085 Fmt 4703 Sfmt 4703 Each affected component separately shall prepare and issue a photographic identification card for qualified retired LEOs. Each such identification card shall, at a minimum, include the name of the individual, the individual’s photograph, an identification number traceable to the bearer, the date the employee retired in good standing from service with the issuing agency, and the phrase ‘‘Retired Law Enforcement Officer.’’ Individual components shall not themselves train or qualify retired employees to carry a firearm, as authorized under the law. In order to be authorized under the Act to carry a firearm, a retired qualified LEO from a DOJ component must qualify pursuant to 18 U.S.C. 926C(d)(2)(B), and in accordance with state standards for active LEOs. It shall be within the discretion of the employing agency to issue the retired LEO credential called for under the Act. Should the agency (1) make a finding that the subject is not qualified, or (2) enter into an agreement in which the subject agrees that he or she is not qualified, the subject shall not be issued the retired LEO credential described above. With respect to the Act’s limitation that a qualified retired LEO ‘‘is not under the influence of alcohol or another intoxicating or hallucinatory drug or substance,’’ each former Department employee seeking such qualification annually must meet state standards, if any, regarding alcohol or drug use by law enforcement officers authorized to carry a firearm. [FR Doc. 05–4282 Filed 3–3–05; 8:45 am] BILLING CODE 4410–20–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances Notice of Registration By Notice dated October 1, 2004, and published in the Federal Register on October 29, 2004, (69 FR 63178), Cambrex North Brunswick Inc., Technology Center of New Jersey, 661 Highway One, North Brunswick, New Jersey 08902, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in Schedules I and II: Drug N-Ethylamphetamine (1475) ........ Tetrahydrocannabinols (7370) ..... E:\FR\FM\04MRN1.SGM 04MRN1 Schedule I I 10676 Federal Register / Vol. 70, No. 42 / Friday, March 4, 2005 / Notices Drug Schedule 2,5-Dimethoxyamphetamine (7396). 3,4-Methylenedioxyamphetamine (7400). 4-Methoxyamphetamine (7411) ... Amphetamine (1100) .................... Methamphetamine (1105) ............ Methylphenidate (1724) ................ Codeine (9050) ............................. Hydromorphone (9150) ................ Hydrocodone (9193) ..................... Methadone (9250) ........................ Methadone Intermediate (9254) ... Morphine (9300) ........................... Sufentanil (9740) .......................... Fentanyl (9801) ............................ I I I II II II II II II II II II II II The company plans to manufacture the listed controlled substances in bulk for distribution to its customers. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Cambrex North Brunswick, Inc., Technology Centre of New Jersey to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Cambrex North Brunswick, Inc., Technology Centre of New Jersey to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. DEPARTMENT OF JUSTICE By Notice dated September 16, 2004, and published in the Federal Register on September 30, 2004, (69 FR 58539– 58540), Cambridge Isotope Laboratory, 50 Frontage Road, Andover, Massachusetts 01810, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in Schedules I and II: DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration By Notice dated September 28, 2004 and published in the Federal Register on October 14, 2004, (69 FR 61043), Cambrex North Brunswick, Inc., Technology Center of New Jersey, 661 Highway One, North Brunswick, New Jersey 08902, made application by renewal to the Drug Enforcement Jkt 205001 BILLING CODE 4410–09–P Manufacturer of Controlled Substances; Notice of Registration BILLING CODE 4410–09–P 19:07 Mar 03, 2005 Dated: February 23, 2005. William J. Walker, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 05–4235 Filed 3–3–05; 8:45 am] Drug Enforcement Administration Dated: February 23, 2005. William J. Walker, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 05–4212 Filed 3–3–05; 8:45 am] VerDate jul<14>2003 Administration (DEA) to be registered as an importer of Phenylacetone (8501), a basic class of controlled substance listed in Schedule II. The company plans to import the listed controlled substances to manufacture amphetamine. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. sections 823(a) and 952(a) and determined that the registration of Cambrex North Brunswick, Inc. to import the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Cambrex North Brunswick, Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. sections 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic class of controlled substance listed. Drug Schedule Methaqualone (2565) ................... Dimethyltryptamine (7435) ........... Amphetamine (1100) .................... Methamphetamine (1105) ............ Pentobarbital (2270) ..................... Secobarbital (2315) ...................... PO 00000 Frm 00086 Fmt 4703 Sfmt 4703 I I II II II II Drug Phencyclidine (7471) .................... Cocaine (9041) ............................. Codeine (9050) ............................. Oxycodone (9143) ........................ Hydromorphone (9150) ................ Oxycodone (9143) ........................ Hydromorphone (9150) ................ Benzoylecgonine (9180) ............... Methadone (9250) ........................ Dextropropoxyphene (9273) ......... Morphine (9300) ........................... Fentanyl (9801) ............................ Schedule II II II II II II II II II II II II The company plans to manufacture small quantities of the listed controlled substances to produce isotope labeled standards for drug analysis. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Cambridge Isotope Laboratory to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Cambridge Isotope Laboratory to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: February 22, 2005. William J. Walker, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 05–4204 Filed 3–3–05; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration By Notice dated September 28, 2004, and published in the Federal Register on October 14, 2004, (69 FR 61043), Cerilliant Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 78664, made application by renewal to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed in Schedules I and II: E:\FR\FM\04MRN1.SGM 04MRN1

Agencies

[Federal Register Volume 70, Number 42 (Friday, March 4, 2005)]
[Notices]
[Pages 10675-10676]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-4212]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances Notice of Registration

    By Notice dated October 1, 2004, and published in the Federal 
Register on October 29, 2004, (69 FR 63178), Cambrex North Brunswick 
Inc., Technology Center of New Jersey, 661 Highway One, North 
Brunswick, New Jersey 08902, made application by renewal to the Drug 
Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of the basic classes of controlled substances listed in 
Schedules I and II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
N-Ethylamphetamine (1475)..................  I
Tetrahydrocannabinols (7370)...............  I

[[Page 10676]]

 
2,5-Dimethoxyamphetamine (7396)............  I
3,4-Methylenedioxyamphetamine (7400).......  I
4-Methoxyamphetamine (7411)................  I
Amphetamine (1100).........................  II
Methamphetamine (1105).....................  II
Methylphenidate (1724).....................  II
Codeine (9050).............................  II
Hydromorphone (9150).......................  II
Hydrocodone (9193).........................  II
Methadone (9250)...........................  II
Methadone Intermediate (9254)..............  II
Morphine (9300)............................  II
Sufentanil (9740)..........................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for distribution to its customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Cambrex North Brunswick, Inc., Technology Centre of New Jersey to 
manufacture the listed basic classes of controlled substances is 
consistent with the public interest at this time. DEA has investigated 
Cambrex North Brunswick, Inc., Technology Centre of New Jersey to 
ensure that the company's registration is consistent with the public 
interest. The investigation has included inspection and testing of the 
company's physical security systems, verification of the company's 
compliance with state and local laws, and a review of the company's 
background and history. Therefore, pursuant to 21 U.S.C. 823, and in 
accordance with 21 CFR 1301.33, the above named company is granted 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed.

    Dated: February 23, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 05-4212 Filed 3-3-05; 8:45 am]
BILLING CODE 4410-09-P